Saleable Returns Verification: What You Need to Know About Enforcement Discretion
There is industry speculation around the FDA announcing a delay in enforcement action for the November 2019 DSCSA saleable returns verification requirement, citing various concerns including industry readiness. Saleable returns not only present a threat to patient safety, they also present a business challenge. Regardless of speculation around enforcement discretion, delaying compliance is not worth the risk, understand why it is critical for your organization to act now.
TraceLink’s Q2 2019 Results Demonstrate Continued Global Momentum
TraceLink announced its Q2 2019 company and financial results, demonstrating strong momentum across all regions. Highlights for the quarter include a 75 percent increase in new year-to-date U.S. bookings, large revenue growth in APAC and India, as well as hosting the largest FutureLink conference to date. In Q2, TraceLink continued to help its 1,200+ customers meet complex serialization requirements, showcasing unmatched network scalability with over 4.1 billion serial numbers commissioned worldwide.
Register Now for FutureLink Nashville
Join TraceLink and your peers October 2-4 at the only event that brings together leaders from across the supply chain to collaborate on the digital transformation evolving within the pharmaceutical supply chain.
The Roadmap to Russia Compliance; Monthly Webinar Series
With less than four months to go until Russia’s first track and trace deadline, there is no time to waste in preparing for the most complex serialization and reporting requirements in the industry. Register for our monthly Russia webinar series, with the next one taking place on September 24, where TraceLink experts will be providing clarity on the most frequently asked questions as the deadlines inch closer.